Group 3: CF participants anticipated to receive CFTR-modulator therapy

Clinical trials for Group 3: CF participants anticipated to receive CFTR-modulator therapy explained in plain language.

Never miss a new study

Get alerted when new Group 3: CF participants anticipated to receive CFTR-modulator therapy trials appear

Sign up with your email to follow new studies for Group 3: CF participants anticipated to receive CFTR-modulator therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New MRI scans could reveal hidden lung changes in cystic fibrosis patients

Knowledge-focused Ongoing

This study uses advanced MRI scans to track lung structure and function in people with cystic fibrosis who are taking CFTR-modulator therapy. Researchers will compare MRI results with standard breathing tests and quality-of-life measures. The study includes healthy volunteers, st…

Matched conditions: GROUP 3: CF PARTICIPANTS ANTICIPATED TO RECEIVE CFTR-MODULATOR THERAPY

Sponsor: The Hospital for Sick Children • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:08 UTC

Group 3: CF participants anticipated to receive CFTR-modulator therapy

Get alerted when new Group 3: CF participants anticipated to receive CFTR-modulator therapy trials appear

New MRI scans could reveal hidden lung changes in cystic fibrosis patients